Join us for a roundtable discussion to gain a deeper understanding of emerging data from ACR 2022 and real-world evidence with biosimilars. Brought to you by our expert chair Julie Ann Lough, and speakers Rieke Alten, Robert Moots & Laurent Peyrin-Biroulet.
‘Key Insights from ACR 2022: An Interdisciplinary Expert Roundtable Discussion’ will spotlight:
- New mechanisms of action, new trends, and data that emerged from ACR 2022
- New data on biosimilars from ACR 2022
- New data on anti-TNFs and real-world evidence with biosimilars
- New uses and data on adalimumab
This educational activity has been supported by a medical education grant from VIATRIS. The webinar is intended for healthcare professionals only.